UNH vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

UNH

49.7
AI Score
VS
UNH Wins

CLOV

34.3
AI Score

Investment Advisor Scores

UNH

50score
Recommendation
BUY

CLOV

34score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric UNH CLOV Winner
Forward P/E 19.8807 81.9672 UNH
PEG Ratio 1.2131 0 Tie
Revenue Growth 0.4% 55.6% CLOV
Earnings Growth 61.5% 0.0% UNH
Tradestie Score 49.7/100 34.3/100 UNH
Profit Margin 3.1% -0.7% UNH
Beta 1.00 1.00 Tie
AI Recommendation BUY SELL UNH

Relative Price Performance (Last 90 Days)

UNH 1M: -7.9% · 3M: +2.0% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

UNH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.9 · Price: $390.11

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric UNH CLOV
Market Cap
Forward P/E 17.2 27.7
Trailing P/E 25.3
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.0%
EPS 15.35 -0.05
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, UNH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.